Pfizer | PFE - Ebitda


Pfizer reported $6.36B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
AbbVie USD 6.91B 3.22B Jun/2026
Abbott USD 2.43B 844M Mar/2026
ALKERMES USD 120.06M 19.15M Sep/2026
Amgen USD 5.8B 1.25B Sep/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Bayer EUR 1.62B 529M Sep/2026
Biogen USD 450.8M 198.9M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Drreddys Laboratories INR 18.79B 10.16B Sep/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Glaxosmithkline GBP 2.93B 154M Sep/2026
J&J USD 8.99B 721M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merck USD 1.42B 2.97B Jun/2026
Neurocrine Biosciences USD 375.3M 185.4M Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Novartis USD 5.36B 45M Sep/2026
Pacira USD 50.45M 1.78M Sep/2026
Perrigo USD 156.6M 83M Sep/2026
Pfizer USD 6.36B 350M Sep/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 89.44M 28.2M Sep/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
Sanofi EUR 6.66B 4.99B Sep/2026
Vertex Pharmaceuticals USD 888.6M 436.6M Sep/2026
Zoetis USD 1.07B 21M Sep/2026